| Title : Memogain is a galantamine pro-drug having dramatically reduced adverse effects and enhanced efficacy - Maelicke_2010_J.Mol.Neurosci_40_135 |
| Author(s) : Maelicke A , Hoeffle-Maas A , Ludwig J , Maus A , Samochocki M , Jordis U , Koepke AK |
| Ref : Journal of Molecular Neuroscience , 40 :135 , 2010 |
| Abstract : Maelicke_2010_J.Mol.Neurosci_40_135 |
| ESTHER : Maelicke_2010_J.Mol.Neurosci_40_135 |
| PubMedSearch : Maelicke_2010_J.Mol.Neurosci_40_135 |
| PubMedID: 19669943 |
Maelicke A, Hoeffle-Maas A, Ludwig J, Maus A, Samochocki M, Jordis U, Koepke AK (2010)
Memogain is a galantamine pro-drug having dramatically reduced adverse effects and enhanced efficacy
Journal of Molecular Neuroscience
40 :135
Maelicke A, Hoeffle-Maas A, Ludwig J, Maus A, Samochocki M, Jordis U, Koepke AK (2010)
Journal of Molecular Neuroscience
40 :135